Prevalence of renal disease in hypertensive patients attended in the castilla y león primary care centers;Prevalencia de lesión renal en pacientes hipertensos atendidos en las consultas de Atención Primaria

Hipertension y Riesgo Vascular

Volumn 27, Issue 5, 2010, Pages 187-194

  Gomez Marcos M A ^a   Cea Calvo, L ^b   Marcos Rodriguez A ^c   Ollauri Nevares, A ^d   Rodriguez Avila Z ^e   Garcia Ortiz L ^a  

^a Biomedical Research Institute of Salamanca IBSAL   (Spain)

^b Medical affairs Merck sharp and Dohme ltd   (Spain)

^c Centro de Salud Universitario Parquesol   (Spain)

^d Centro de Salud Soria Norte   (Spain)

^e Centro de Salud Ponferrada II   (Spain)

Author keywords

Hypertension; Kidney diseases; Primary care

Indexed keywords

CREATININE;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE;

EID: 77957155793     PISSN: 18891837     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hipert.2009.11.002     Document Type: Article

References (34)

1. Ezzati M., Lopez A.D., Rodgers A., Vander Hoorn S., Murray C.J. Selected major risk factors and global and regional burden of disease. Lancet 2002, 360:1347-1360. Comparative Risk Assessment Collaborating Group.
2. Kannel W.B., Gordon T., Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med 1969, 71:89-105.
3. Verdecchia P., Porcellati C., Reboldi G., Gattobigio R., Borgioni C., Pearson T.A., et al. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 2001, 104:2039-2044.
4. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalisation. N Engl J Med 2004, 351:1296-1306.
5. Manjunath G., Tighiouart H., Coresh J., Macleod B., Salem D.N., Griffith J.L., et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003, 63:1121-1129.
6. Anavekar N.S., McMurray J.J.V., Velazquez E.J., Solomon S.D., Kober L., Rouleau J.L., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004, 351:1285-1295.
7. Rahman M., Pressel S., Davis B.R., Nwachuku C., Wright Jr.J.T., Whelton P.K., et al. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006, 144:172-180.
8. Hillege H.L., Fidler V., Diercks G.F., van Gilst W.H., de Zeeuw D., van Veldhuisen D.J., et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002, 106:1777-1782.
9. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001, 286:421-426.
10. Wachtell K., Ibsen H., Olsen M.H., Borch-Johnsen K., Lindholm L.H., Mogensen C.E., et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003, 139:901-906.
11. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano R., et al. European Society of Hypertension-European Society of Cardiology guidelines for management of arterial hypertension. J Hypertens 2007, 25:1105-1187.
12. Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2007, 28:2375-2414.
13. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
14. Cea-Calvo L., Redón J., Martí-Canales J.C., Lozano J.V., Llisterri J.L., Fernández-Pérez C., et al. Prevalence of low glomerular filtration rate in the elderly population of Spain. The PREV-ICTUS study [Article in Spanish]. Med Clin (Barc) 2007, 129:681-687.
15. De Francisco A.L., De la Cruz J.J., Cases A., de la Figuera M., Egocheaga M.I., Górriz J.I., et al. Prevalence of kidney insufficiency in primary care population in Spain: EROCAP study [Article in Spanish]. Nefrologia 2007, 27:300-312.
16. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147.
17. Casale P.N., Devereux R.B., Alonso D.R., Campo E., Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation 1987, 75:565-572.
18. Sokolow M., Lyon T. Ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949, 37:161-186.
19. Palatini P., Graniero G.R., Mormino P., Mattarei M., Sanzuol F., Cignacco G.B., et al. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST Study). Am J Hypertens 1996, 9:334-341.
20. Pontremoli R., Sofia A., Ravera M., Nicolella C., Viazzi F., Tirotta A., et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC Study. Hypertension 1997, 30:1135-1143.
21. Roberto Robles N., Velasco J., Mena C., Angulo E., Garrote T. MICREX Study. Microalbuminuria en pacientes diabéticos y en pacientes con hipertensión arterial: estudio de una cohorte de 979 pacientes. Med Clin (Barc) 2006, 127:761-764.
22. Giner V., Tormos C., Chaves F.J., Saez G., Redon J. Microalbuminuria and oxidative stress in essential hypertension. J Intern Med 2004, 255:588-594.
23. Martínez V.B., González-Juanatey J.R., Bertomeu-González V., Fácil L., Mazón P., Quiles J., et al. Infravaloración del riesgo renal en consultas de cardiología. Estudio RICAR. Nefrología 2008, 28:621-626.
24. De la Sierra A., Egocheaga M.I., Aguilera M.T. Prevalencia y características clínicas de la microalbuminuria en la población española con hipertensión arterial. Med Clin (Barc) 2008, 130:201-205.
25. Pozuelos Estrada G., Molina Martínez L., Romero Perera J.J., Díaz Herrera N., Cañón Barroso L., Buitrago Ramírez F. Prevalencia de insuficiencia renal oculta estimada mediante formulas de calculo del grado de función renal en hipertensos mayores de 60 años, remitidos para medicion ambulatoria de la presion arterial. Aten Primaria 2007, 39:247-253.
26. Ruilope L.M., Palmer C., De Leeuw P., Morris B.J., Castaigne A., Rosenthal T., et al. Evaluation of different parameters of renal function as predictors of primary outcome in the INSIGHT study [resumen]. J Hypertens 2001, 19:223.
27. Mann J.F.E., Gerstein H.C., Pogue J., Bosch J., Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001, 134:629-636.
28. Almirall J., Vaqueiro M., Antón E., Baré M.L., González V., Jaimez E., et al. Centros de Asistencia Primaria (Grupo del proyecto "D'AVIS"). Prevalencia de la insuficiencia renal en la población general mayor de 64 años y episodios cardio-vasculares asociados. Nefrología 2005, 25:655-662.
29. Lahoz C., Mostaza J.M., Mantilla M.T., Taboada M., Tranche S., Martín-Jadraque R., et al. Insuficiencia renal crónica oculta en pacientes con enfermedad coronaria estable. Med Clin (Barc) 2008, 131:241-244.
30. Llisterri Caro J.L., Gorriz Teruel J.L., Alonso Moreno F.J., Manzanera Escribano M.J., Rodríguez Roca G.C., Barrios Alonso V., et al. Grupos de Trabajo de Riesgo Cardiovascular y de Hipertensión Arterial de la Sociedad Española de Medicina Rural y Generalista and the researchers of the LIPICAP study. Prevalencia de la enfermedad renal crónica oculta en la población dislipémica asistida en atención primaria. Estudio LIPICAP. Med Clin (Barc) 2008, 130:127-132.
31. Fernandez Villaverde J.M., Maestro Saavedra F.J., Allut Vidal G., Grigorian Shamagian L., Otero-Ravina F., Gonzalez-Juanatey J.R. High prevalence of left ventricular hypertrophy in patients with hypertension of long course. Med Clin (Barc) 2007, 129:46-50.
32. Lozano J.V., Redon J., Cea-Calvo L., Fernandez-Perez C., Navarro J., Bonet A., et al. Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study. Rev Esp Cardiol 2006, 59:136-142.
33. Brosius F.C., Hostetter T.H., Kelepouris E., Mitsnefes M.M., Moe S.M., Moore M.A., et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease. A science advisory form the American Heart Association Kidney and Cardiovascular Disease Council; the Councils for High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2006, 114:1083-1087.
34. Executive summary. Am J Kidney Dis 2002, 39:S17-S31.